Colorado unveils its plan for a state public option—and it could cut provider payments dramatically

Colorado officials on Monday released a draft report outlining a proposed state public health insurance option, but the plan is drawing criticism from health care providers who would receive lower reimbursements under the proposal.

Read More

How nurses get paid, in 5 charts

Medscape on Wednesday released its annual RN/LRN Compensation report, and this year's report shows that 49% of RNs and 58% of LPNs do not feel fairly compensated. Find out how nurse pay varies by gender, practice setting, geography, and more on our interactive charts.

How Denver Health is finding homes for patients—without 'stranding' them in the hospital

Health systems across the country are testing ways to help patients who are healthy enough to leave but lack a safe place to go after discharge find affordable housing, Markian Hawryluk reports for Kaiser Health News.

Weekend reads: 'Sesame Street' wants to help kids cope with parental substance use

Georgia officials warn about a fish that can live on land, how four pre-teen detectives found a dementia patient who'd left her care center, and more.

What it's like to survive the mysterious, vaping-linked lung illness

After vaping for years, 18-year-old Piper Johnson spent a week in the ICU with a lung illness officials say is linked to e-cigarette use and vaping. Now, she's warning other teenagers of the risks, and urging them to kick their vaping habit, Allison Aubrey reports for NPR.

New HIV-prevention drug gets FDA approval—but not for cisgender women

FDA on Thursday approved Gilead Science's Descovy to prevent HIV infection in men and transgender women, and some critics are taking issue with the agency's decision to approve the drug before Gilead tested it on a large scale in cisgender women, Apoorva Mandavilli reports for the New York Times.

Around the nation: California bans pesticide linked to health defects in kids

Beginning in early 2020, chlorpyrifos, a pesticide linked to brain damage and other health defects in children, will no longer be sold in California, in today's bite-sized hospital and health industry news from California, Kentucky, and Virginia.